Posts

Showing posts with the label Colorectal Cancer competitive landscape

Colorectal Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Colorectal cancer, commonly known as colon cancer, primarily arises in the colon or rectum; it is the third most prevalent form of cancer known for its slow progression over many years. Typically, it originates as a non-malignant polyp, an unusual tissue growth lining the colon. There are three main presentations of colorectal cancer: sporadic (70%), familial clustering (20%), and inherited syndrome (10%). Various risk factors are linked to the development of colon cancer, including age, environmental factors, diets high in animal fat, obesity, smoking, excessive alcohol consumption, genetic predisposition, and a history of inflammatory bowel disease. The most prevalent type of colon cancer diagnosed in patients is adenocarcinoma. Colorectal cancer development hinges on the adenoma-carcinoma sequence, characterized by a gradual accumulation of genetic alterations. In sporadic colorectal cancers, the gatekeeper pathway, governed by a gene that regulates growth, accounts for roughly...

Colorectal Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
  Colorectal cancer, also known as colon cancer, appears in the colon or the rectum and is the third leading cause of cancer that develops slowly over several years. It usually begins as a non-cancerous polyp, an abnormal growth of tissue that lines the colon. Colorectal cancer can manifest as sporadic (70%), familial clustering (20%), and inherited syndrome (10%). Several risk factors are associated with colon cancer, including age, environment, diets with high animal fat, obesity, cigarette smoking, heavy alcohol consumption, hereditary, and history of inflammatory bowel disease. The most common type of colon cancer found in patients diagnosed is adenocarcinoma. The adenoma-carcinoma sequence is the base for colorectal cancer development, with a build-up of genetic alteration. The gatekeeper (gene that regulates growth) pathway accounts for approximately 85% of sporadic colorectal cancers and is the mechanism of carcinogenesis in FAP patients. Mutation of the tumor-suppressor gen...

Colorectal Cancer – Market outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
  Colorectal cancer, also known as colon cancer, appears in the colon or the rectum and is the third leading cause of cancer that develops slowly over several years. It usually begins as a non-cancerous polyp, an abnormal growth of tissue that lines the colon. Colorectal cancer can manifest as sporadic (70%), familial clustering (20%), and inherited syndrome (10%). Several risk factors are associated with colon cancer, including age, environment, diets with high animal fat, obesity, cigarette smoking, heavy alcohol consumption, hereditary, and history of inflammatory bowel disease. The most common type of colon cancer found in patients diagnosed is adenocarcinoma. The adenoma-carcinoma sequence is the base for colorectal cancer development, with a build-up of genetic alteration. The gatekeeper (gene that regulates growth) pathway accounts for approximately 85% of sporadic colorectal cancers and is the mechanism of carcinogenesis in FAP patients. Mutation of the tumor-suppressor gen...